Vyvanse (Lisdexamfetamine) Can Cause Heart Palpitations in ADHD Patients
Yes, Vyvanse (lisdexamfetamine) can cause heart palpitations in individuals with ADHD, as stimulant medications are known to increase heart rate and blood pressure in some patients. 1, 2
Cardiovascular Effects of Vyvanse
Vyvanse is a prodrug that is converted to dextroamphetamine in the body and can affect the cardiovascular system in several ways:
- Stimulant medications, including Vyvanse, increase heart rate by an average of 1-2 beats per minute and blood pressure by 1-4 mmHg 2
- A subset of individuals (5-15%) may experience more substantial increases in heart rate and blood pressure 2
- The FDA drug label for Vyvanse specifically lists palpitations as a reported adverse reaction 1
- In clinical trials, 2% of adult patients taking Vyvanse reported palpitations (compared to 0% on placebo) 1
- Tachycardia was reported in 1% of adult patients discontinuing Vyvanse due to adverse effects 1
Risk Factors and Monitoring
Certain factors may increase the risk of experiencing cardiovascular side effects with Vyvanse:
- Personal history of cardiac symptoms 2
- Family history of sudden death, cardiovascular symptoms, Wolff-Parkinson-White syndrome, hypertrophic cardiomyopathy, or long QT syndrome 2
- Pre-existing hypertension or tachyarrhythmias 3
- Higher doses of stimulant medication 4
Management Recommendations
If a patient experiences palpitations while taking Vyvanse:
- Monitor heart rate and blood pressure regularly during treatment 2, 5
- Consider dose reduction if palpitations or other cardiovascular symptoms occur 3
- Schedule medication earlier in the day to minimize sleep disturbance that can exacerbate palpitation awareness 3
- For patients with significant cardiovascular risk factors, consider obtaining an ECG before starting treatment 2
- In cases of severe or persistent palpitations, consider switching to a non-stimulant medication for ADHD (such as atomoxetine, guanfacine, or clonidine) 2
Clinical Perspective
Despite these cardiovascular effects, it's important to note:
- The overall risk of serious cardiovascular events with stimulant medications is extremely low 2, 6
- Studies have not shown an increased risk of sudden cardiac death in patients taking stimulants compared to those not receiving stimulants 2
- The benefits of treating ADHD with appropriate medication typically outweigh the cardiovascular risks for most patients 6
- A systematic review found that while stimulants like Vyvanse do cause statistically significant increases in heart rate and blood pressure, these changes are generally small and clinically insignificant for most patients 4
Special Considerations
- Patients with pre-existing cardiovascular conditions should be monitored more closely 2, 6
- Discontinuation of stimulant medication due to cardiovascular effects occurs in approximately 2% of patients 4
- In most cases, cardiovascular effects resolve spontaneously or with dose adjustments 4
- The cardiovascular profile of Vyvanse is similar to that of other stimulant medications used to treat ADHD 7
If palpitations persist or are severe, the medication should be tapered rather than abruptly discontinued, and alternative ADHD treatments should be considered 2.